Compare OGN & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGN | GABC |
|---|---|---|
| Founded | 1923 | 1910 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2020 | 1995 |
| Metric | OGN | GABC |
|---|---|---|
| Price | $5.85 | $41.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $11.75 | ★ $46.50 |
| AVG Volume (30 Days) | ★ 3.0M | 128.3K |
| Earning Date | 04-30-2026 | 04-27-2026 |
| Dividend Yield | 1.32% | ★ 2.98% |
| EPS Growth | N/A | ★ 8.13 |
| EPS | 0.72 | ★ 3.06 |
| Revenue | ★ $6,216,000,000.00 | $487,401,000.00 |
| Revenue This Year | $0.42 | $17.03 |
| Revenue Next Year | $1.67 | $3.92 |
| P/E Ratio | ★ $8.42 | $13.61 |
| Revenue Growth | N/A | ★ 37.80 |
| 52 Week Low | $5.76 | $32.75 |
| 52 Week High | $14.94 | $45.00 |
| Indicator | OGN | GABC |
|---|---|---|
| Relative Strength Index (RSI) | 25.56 | 51.62 |
| Support Level | N/A | $37.28 |
| Resistance Level | $7.87 | $42.40 |
| Average True Range (ATR) | 0.22 | 0.86 |
| MACD | 0.00 | 0.20 |
| Stochastic Oscillator | 10.00 | 72.78 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.